Compass Therapeutics, Inc. (CMPX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings ...
The head of Berkshire Hathaway HomeServices denied the Wall Street Journal’s report claiming Compass was in “advanced talks” to acquire the company, The Real Deal’s Jake I ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results